Funded Biotechnology Startups in Birmingham
The 10 most recent funded biotechnology rounds across both Birminghams — Alabama and the United Kingdom — skew heavily early-stage.
The 10 most recent funded biotechnology rounds across both Birminghams — Alabama and the United Kingdom — skew heavily early-stage. Birmingham, Alabama accounts for 7 of the 10 entries, with the dataset's two largest rounds concentrated there: Yuva Biosciences closed an $8M Seed in February 2024 and Acclinate followed with a $7M Series A in May 2024. Outside those two, round sizes compress sharply, with six of the remaining eight falling between $550K and $3M. The three UK entries — Linear Diagnostics, FourPlus Immersive, and Adapttech — each raised $1M–$3M and are all classified as Series Unknown or Venture.
Disclosed round types are sparse. Only Acclinate carries a confirmed Series A label; Yuva Biosciences is the sole Seed. The rest are Series Unknown or Venture - Series Unknown, which limits stage-based filtering. Activity has remained continuous: AI Metrics raised $950K in November 2025, the most recent round shown, while the oldest entry, Adapttech's $3M in April 2022, marks the dataset's floor.
Most recent rounds
10 shownRelated listings
Frequently asked
What are the largest recent rounds among Birmingham biotechnology companies in this dataset?
Yuva Biosciences leads with an $8M Seed round closed February 2024, followed by Acclinate's $7M Series A in May 2024 — both in Birmingham, Alabama, and both closing within roughly three months of each other. The next tier is Endomimetics and Adapttech, each at $3M.
Are these companies in Birmingham, Alabama or Birmingham, UK?
Seven of the 10 companies are in Birmingham, Alabama: AI Metrics, TIXiMED, Endomimetics, Acclinate, Yuva Biosciences, Southern Research, and CirculoGene Theranostics. The remaining three — Linear Diagnostics, FourPlus Immersive, and Adapttech — are in Birmingham, United Kingdom.
How recent is the funding activity in this segment?
AI Metrics' $950K venture round in November 2025 is the most recent in the set. There are at least two rounds from 2025, four from 2024, two from 2023, and one each from 2022, indicating sustained deal flow over a roughly three-year span.
What round stages appear most often here?
The majority are classified as Series Unknown or Venture - Series Unknown, with only one confirmed Series A (Acclinate, $7M) and one Seed (Yuva Biosciences, $8M) in the 10 rows shown. The prevalence of unknown-stage labels limits stage-based prospecting without additional diligence.
What is the typical disclosed round size for biotechnology companies in this group?
Stripping out the two outliers — Yuva Biosciences at $8M and Acclinate at $7M — the remaining eight rounds range from $550K (TIXiMED) to $3M (Endomimetics, Adapttech), with several clustering around $750K–$1M. This profile is consistent with pre-revenue or early clinical-stage activity.
Which Birmingham biotechnology companies have raised the most recently?
AI Metrics raised $950K in November 2025 and Linear Diagnostics raised $1M in June 2025, making them the two most recently funded companies in this set. Both rounds are classified as Series Unknown, and the companies are in Birmingham, Alabama and Birmingham, UK respectively.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.